本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

爵士制药

127.75
+1.621.28%
盘后128.000.2500+0.20%18:03 EDT
成交量:67.56万
成交额:8,612.42万
市值:77.49亿
市盈率:-19.26
高:128.13
开:126.06
低:125.56
收:126.13
52周最高:148.06
52周最低:95.49
股本:6,065.88万
流通股本:5,865.43万
量比:0.89
换手率:1.15%
股息:- -
股息率:- -
每股收益(TTM):-6.6339
每股收益(LYR):9.06
净资产收益率:-10.84%
总资产收益率:5.19%
市净率:2.09
市盈率(LYR):14.10

数据加载中...

2025/04/25

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/04/21

重要事件披露

Form 8-K - Current report
2025/04/08

重要事件披露

Form 8-K - Current report
2025/04/04

SEC问询函

Form CORRESP - Correspondence
2025/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/03/05

重要事件披露

Form 8-K - Current report
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities